Calcific aortic stenosis.
Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P.
Nat Rev Dis Primers. 2016 Mar 3;2:16006. doi: 10.1038/nrdp.2016.6.
Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.
Pasipoularides A.
J Cardiovasc Transl Res. 2016 Aug;9(4):374-99. doi: 10.1007/s12265-016-9695-z. Epub 2016 May 16.
Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Tobe A, Tanaka A, Tokuda Y, Akita S, Fujii T, Miki Y, Furusawa K, Ishii H, Usui A, Murohara T.
Circ J. 2021 Jun 25;85(7):1093-1098. doi: 10.1253/circj.CJ-21-0354. Epub 2021 May 25.
Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease.
Kim M, Choi JH, Kim HK, Kim HL, Shin SH, Jang JY, Park JH, Kim KH, Hong GR, Park SM, Lee SA, Kang DH.
Am Heart J. 2024 Feb;268:45-52. doi: 10.1016/j.ahj.2023.11.012. Epub 2023 Nov 23.
Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
Koga M, Izumo M, Yoneyama K, Akashi YJ, Yashima F, Tada N, Yamawaki M, Shirai S, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Takagi K, Watanabe Y, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators.
Am J Cardiol. 2023 Oct 1;204:130-139. doi: 10.1016/j.amjcard.2023.07.101. Epub 2023 Aug 2.
Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
Dahiya G, Kyvernitakis A, Joshi AA, Lasorda DM, Bailey SH, Raina A, Biederman RWW, Kanwar MK.
Int J Cardiovasc Imaging. 2021 Feb;37(2):485-492. doi: 10.1007/s10554-020-02015-z. Epub 2020 Sep 9.
Impact of Obesity on Persistent Left Ventricular Hypertrophy After Aortic Valve Replacement for Aortic Stenosis.
Einarsen E, Saeed S, Cramariuc D, Chambers JB, Midtbø H, Gerdts E.
Am J Cardiol. 2019 Mar 15;123(6):942-947. doi: 10.1016/j.amjcard.2018.12.012. Epub 2018 Dec 19.
Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
Pedersen ALD, Povlsen JA, Rasmussen VG, Frederiksen CA, Christiansen EH, Terkelsen CJ, Vase H, Poulsen SH.
Int J Cardiovasc Imaging. 2023 Jan;39(1):13-22. doi: 10.1007/s10554-022-02688-8. Epub 2022 Jul 19.
Basal Septal Hypertrophy and Procedural Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
Tomii D, Okuno T, Heg D, Lanz J, Praz F, Stortecky S, Windecker S, Pilgrim T.
JACC Cardiovasc Interv. 2022 Aug 22;15(16):1688-1690. doi: 10.1016/j.jcin.2022.06.026. Epub 2022 Jul 27.
Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement.
Tanaka T, Yahagi K, Asami M, Ninomiya K, Kikushima H, Okuno T, Horiuchi Y, Yuzawa H, Komiyama K, Tanaka J, Yokozuka M, Miura S, Aoki J, Tanabe K.
J Cardiol. 2021 Apr;77(4):346-352. doi: 10.1016/j.jjcc.2020.12.017. Epub 2021 Jan 15.
